News
Novo Nordisk’ chief executive Lars Fruergaard ... be the only industry representative in the GLP-1 agonist market to testify at the hearing. At BIO 2025, vaccines were top of mind as a result ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results